awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35795427-6BFAAA05-9313-499D-BC67-B27AA27E136B
Q35795427-6BFAAA05-9313-499D-BC67-B27AA27E136B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35795427-6BFAAA05-9313-499D-BC67-B27AA27E136B
Effect and Tolerability of Agalsidase Alfa in Patients with Fabry Disease Who Were Treatment Naïve or Formerly Treated with Agalsidase Beta or Agalsidase Alfa.
P2860
Q35795427-6BFAAA05-9313-499D-BC67-B27AA27E136B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35795427-6BFAAA05-9313-499D-BC67-B27AA27E136B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e059af3f82514af1e0d0e5742c4f13388b48df7
P2860
Long-term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS-LSD cohort study.